Company intelligence / Profile preview
eTheRNA
Niel, Flanders, Belgiumetherna.be ↗
- Ownership
- Private
- Employees
- ~96
- Development stage
- Preclinical
01
Overview
eTheRNA has demonstrated the ability of its proprietary mRNA and LNP platforms to deliver targeted biodistribution and immune activation. Its lead programs are focused on cancer immunotherapy using dendritic cell-targeted approaches. The company’s TriMix platform has shown promise in boosting immune responses with a favorable safety profile. Some programs have advanced into clinical trials targeting solid tumors and infectious diseases, but detailed late-stage results are not publicly available as of June 2025.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- mRNA therapeuticsLipid Nanoparticles (LNPs)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Notable partnerships with pharma/biotech companies for RNA therapeutics development; specific partners include Leaps by Bayer for inverse RNA vaccines research.
Beyond the preview
Go deeper on eTheRNA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on eTheRNA.